Wound Debridement Products Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Gels, Ointments and Creams, Surgical Devices, Medical Gauzes, Mechanical Debridement Pads, Ultrasound Devices, Others), By Method (Autolytic, Enzymatic, Surgical, Mechanical, Others), By Application (Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical and Traumatic Wounds, Burns, Burns) and Region Forecast 2019-2030  

Wound Viability Assessment Market size was valued at US$ 22.89 billion in 2023 and is poised grow at a CAGR of 4.2% from 2024 to 2030. The wound viability assessment market plays a crucial role in modern healthcare, aiding in the effective treatment of chronic wounds like diabetic ulcers and pressure injuries. By evaluating wound healing potential, these assessments guide clinicians in selecting optimal treatment strategies, ultimately improving patient outcomes and reducing healthcare costs. In addition, chronic wounds, such as diabetic ulcers and pressure injuries, pose a significant healthcare challenge worldwide.

The prevalence of these wounds is on the rise, driven by factors like aging population, increased life expectancy, and lifestyle factors. This growing burden of chronic wounds underscores the need for advanced wound care solutions, including wound viability assessments. Moreover, growing public awareness regarding health issues, including chronic wounds, is fostering demand for advanced treatment options. Patients are becoming increasingly knowledgeable about wound care and are seeking active participation in their treatment plans.

Wound viability assessments empower patients by providing objective data on wound healing potential, allowing for informed decision-making alongside healthcare professionals. Furthermore, growing recognition of the importance of effective wound care is leading to government initiatives and favourable reimbursement policies for wound assessment technologies in various countries. These supportive policies encourage healthcare providers to adopt these solutions, contributing to market expansion. However, some wound viability assessment technologies, particularly those relying on advanced methods, can generate complex data sets.  Interpreting this data requires trained personnel who understand the nuances of the technology and its limitations.  A lack of skilled professionals can pose a challenge for some healthcare institutions.

Key Developments

• In June 2023, Wound dressing epicite balance was first offered by JeNaCell to the German market. This dressing is ideal for pressure ulcers, diabetic foot ulcers, venous leg ulcers, arterial leg ulcers, and soft tissue lesions. This strategic launch intended to expand the company’s offering and enhance revenue.
• In January 2023, Convatec launched the ConvaFoam in U.S.A., ConvaFoam is a line of sophisticated foam dressings made to satisfy the needs of healthcare providers and their patients. This product launch expanded the company’s product portfolio, delivering a substantial competitive edge.